Evidence map›Paper›PMID 39535709›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

RNA Decay Assay: 5-Ethynyl-Uridine Labeling and Chasing.

Haripriya Gupta, Jayden R Lee, Kane B Hoffman, Kyung-Won Min, Je-Hyun Yoon

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. RNA Labeling of Nucleolar Transcripts by 5-Ethynyl Uridine Click Chemistry.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haripriya GuptaDepartment of Oncology Science, University of Oklahoma, Oklahoma City, OK, USA.
Jayden R Lee *Department of Oncology Science, University of Oklahoma, Oklahoma City, OK, USA.
Kane B Hoffman *Department of Oncology Science, University of Oklahoma, Oklahoma City, OK, USA.
Kyung-Won MinDepartment of Biology, Gangneung-Wonju National University, Gangneung, Republic of Korea. minkw@gwnu.ac.kr.
Je-Hyun YoonDepartment of Oncology Science, University of Oklahoma, Oklahoma City, OK, USA. jehyun-yoon@ouhsc.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eukaryotic RNA synthesis and degradation are intricately regulated, impacting on gene expression dynamics. RNA stability varies in individual transcripts and is modulated by trans-acting factors such as microRNAs, long noncoding RNAs, and RNA-binding proteins, which determine protein output and subsequent cellular processes. To measure RNA decay rate, accurate and reliable methodologies are essential in the field of RNA biology. Transcription inhibition and metabolic labeling enable comprehensive investigations on RNA decay, offering critical insights into dynamic regulation of RNA decay. Transcription shut-off has been employed widely by using various approaches, such as treatment with chemical inhibitors or generation of temperature-sensitive mutants of RNA polymerases. However, it has limitations, providing a static view and lacking real-time dynamics as well as precise measurement of decay rate. Metabolic labeling, a method of incorporating modified nucleotides into RNA transcripts, complements shut-off approaches, allowing selective monitoring of newly synthesized RNA and tracing decay intermediates. The purpose of the protocol described in this chapter is to assess the kinetics and statics of newly synthesized RNA and its decay by 5-ethynyl uridine labeling.

Indexed as

RNA StabilityUridineRNARNA, MessengerStaining and LabelingTranscription, GeneticRNARNA, MessengerUridineMetabolic labelingmRNA decayqPCR

Identifiers

PMID39535709

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.